Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Radient files cancer test patent in China, Japan
Onko-Sure blood test kit is a 96-well Enzyme-linked immunosorbent assay (ELISA) which is used to detect and treat 19 different types of cancers. Radient Pharmaceuticals chairman and CEO
Onko-Sure blood test kit is a 96-well Enzyme-linked immunosorbent assay (ELISA) which is used to detect and treat 19 different types of cancers. Radient Pharmaceuticals chairman and CEO
The chemicals present in bath salts including mephedrone, methylenedioxypyrovalerone (MDPV) and methylone have been banned for around one year for public safety, Reuters reported. A permanent ban on
MANF is a potent neurotrophic factor which is used to treat apoptosis-related diseases including Parkinson’s disease. Amarantus claims to protect its compositions of matter and methods of use
Phase one of the expansion, which involves an investment of £4.5m, will provide a non-GMP formulation development facility for the development and scale-up of solid oral dose drug
Papaverine, an opium alkaloid is used to treat visceral spasm, vasospasm, and erectile dysfunction, besides being used as a smooth muscle relaxant in microsurgery. The FDA held Papaverine
Bupivacaine hydrochloride is used for inducing local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Bupivacaine
Kollicoat Smartseal 30 D is a water-based reverse enteric polymer having both taste masking and moisture barrier properties. The pre-formulated additive system prepares and applies the polymer in
Flexel for Magnetic Mixers is a non-invasive, mixing unit that uses Sartorius Stedim Biotech Flexel 3D bag technology, the stainless steel Palletank container and ATMI patented mixing technology.
Syntaxin will help in the discovery of new therapeutic candidates and Ipsen will aid in pharmacological, preclinical and clinical assessments of the newly discovered compounds. As per the
Rituximab helps in the reduction of B-lymphocytes. The placebo-controlled Phase II study comprised 30 ME/CFS patients who were randomised to either treatment with Rituximab or saline. It was